Dr. Ervin Szoke, MD (he/him) is an Endocrinologist in Melbourne, FL with over 16 years of experience. What is your opinion of Dr. Ervin Szoke, MD? Rate this provider below so other people can make informed decision.
Over 16 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Ervin Szoke, MD has received over $36,119 which includes payments from the following companies:
$27,626.46 from Novo Nordisk Inc
$1,498.81 from sanofi-aventis U.S. LLC
$846.06 from LILLY USA, LLC
$637.05 from Janssen Pharmaceuticals, Inc
$495.04 from Shire North American Group Inc
$489.94 from Boehringer Ingelheim Pharmaceuticals, Inc.
$474.04 from Amgen Inc.
$450.93 from AstraZeneca Pharmaceuticals LP
$382.68 from Medtronic MiniMed, Inc.
$343.95 from GlaxoSmithKline, LLC.
$308.85 from Merck Sharp & Dohme Corporation
$298.20 from Amarin Pharma Inc.
$247.71 from MannKind Corporation
$209.56 from Radius Health, Inc.
$201.30 from AbbVie, Inc.
$190.78 from Salix Pharmaceuticals, a division of Bausch Health US, LLC
$183.17 from Tandem Diabetes Care, Inc.
$177.58 from GENZYME CORPORATION
$126.40 from Abbott Laboratories
$91.36 from Gemini Laboratories, LLC
Payments received by Dr. Ervin Szoke, MD were from the following categories:
$24,562.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!